DK332888A - FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE - Google Patents
FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USEInfo
- Publication number
- DK332888A DK332888A DK332888A DK332888A DK332888A DK 332888 A DK332888 A DK 332888A DK 332888 A DK332888 A DK 332888A DK 332888 A DK332888 A DK 332888A DK 332888 A DK332888 A DK 332888A
- Authority
- DK
- Denmark
- Prior art keywords
- derivative
- manufacturing
- factor viii
- viii
- factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19873720246 DE3720246A1 (en) | 1987-06-19 | 1987-06-19 | FACTOR VIII: C-LIKE MOLECULE WITH COAGULATION ACTIVITY |
Publications (2)
Publication Number | Publication Date |
---|---|
DK332888D0 DK332888D0 (en) | 1988-06-17 |
DK332888A true DK332888A (en) | 1988-12-20 |
Family
ID=6329877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK332888A DK332888A (en) | 1987-06-19 | 1988-06-17 | FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0295597A3 (en) |
JP (1) | JPS6425799A (en) |
KR (1) | KR890000666A (en) |
AU (1) | AU609829B2 (en) |
DE (1) | DE3720246A1 (en) |
DK (1) | DK332888A (en) |
FI (1) | FI882890A (en) |
PT (1) | PT87752B (en) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5661008A (en) * | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
SE468050C (en) * | 1991-03-15 | 1998-04-27 | Pharmacia & Upjohn Ab | Recombinant human factor VIII derivative |
AU6456096A (en) * | 1995-07-11 | 1997-02-10 | Chiron Corporation | Lysine 1689 factor viii:c polypeptide analogs |
US8183344B2 (en) | 1996-04-24 | 2012-05-22 | University Of Michigan | Inactivation resistant factor VIII |
EP1754718B1 (en) | 1996-04-24 | 2011-03-23 | The Regents Of The University Of Michigan | Inactivation resistant factor VIII |
EP1038959A1 (en) | 1999-03-17 | 2000-09-27 | Aventis Behring Gesellschaft mit beschränkter Haftung | Factor VIII without B-domain, comprising one or more insertions of a truncated intron I of factor IX |
EP1233064A1 (en) | 2001-02-09 | 2002-08-21 | Aventis Behring Gesellschaft mit beschränkter Haftung | Modified factor VIII cDNA and its use for the production of factor VIII |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
WO2010091122A1 (en) | 2009-02-03 | 2010-08-12 | Amunix, Inc. | Extended recombinant polypeptides and compositions comprising same |
US20120263701A1 (en) | 2009-08-24 | 2012-10-18 | Volker Schellenberger | Coagulation factor vii compositions and methods of making and using same |
ES2717902T5 (en) | 2009-10-02 | 2022-11-29 | Childrens Hospital Philadelphia | Compositions and methods for improving the function of coagulation factor VIII |
HUE036233T2 (en) | 2009-12-06 | 2018-06-28 | Bioverativ Therapeutics Inc | Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
EP3508573A1 (en) | 2010-07-09 | 2019-07-10 | Bioverativ Therapeutics Inc. | Systems for factor viii processing and methods thereof |
KR20140002601A (en) | 2010-07-09 | 2014-01-08 | 바이오겐 이데크 헤모필리아 인코포레이티드 | Chimeric clotting factors |
EP3527218A1 (en) | 2011-06-10 | 2019-08-21 | Bioverativ Therapeutics Inc. | Pro-coagulant compounds and methods of use thereof |
EP4169525A1 (en) | 2011-07-08 | 2023-04-26 | Bioverativ Therapeutics Inc. | Factor viii chimeric and hybrid polypeptides, and methods of use thereof |
US10656167B2 (en) | 2011-07-25 | 2020-05-19 | Bioverativ Therapeutics Inc. | Assays to monitor bleeding disorders |
CA2850579A1 (en) | 2011-10-18 | 2013-04-25 | Carsten Horn | Method for improving the stability of purified factor viii after reconstitution |
EA029560B1 (en) | 2012-01-12 | 2018-04-30 | Байоджен Эмэй Инк. | Use of chimeric blood coagulation factor for reducing inhibitory immune response in a subject |
CN104271150A (en) | 2012-01-12 | 2015-01-07 | 比奥根艾迪克Ma公司 | Chimeric factor viii polypeptides and uses thereof |
EP2822577B1 (en) | 2012-02-15 | 2019-02-06 | Bioverativ Therapeutics Inc. | Recombinant factor viii proteins |
LT2814840T (en) | 2012-02-15 | 2020-02-25 | Bioverativ Therapeutics Inc. | Factor viii compositions and methods of making and using same |
EP4079316A1 (en) | 2012-06-08 | 2022-10-26 | Bioverativ Therapeutics Inc. | Procoagulant compounds |
WO2013185114A2 (en) | 2012-06-08 | 2013-12-12 | Biogen Idec Ma Inc. | Chimeric clotting factors |
EP3404105A1 (en) | 2012-07-06 | 2018-11-21 | Bioverativ Therapeutics Inc. | Cell line expressing single chain factor viii polypeptides and uses thereof |
PT2882450T (en) | 2012-07-11 | 2020-02-19 | Bioverativ Therapeutics Inc | Factor viii complex with xten and von willebrand factor protein, and uses thereof |
US10001495B2 (en) | 2012-07-25 | 2018-06-19 | Bioverativ Therapeutics Inc. | Blood factor monitoring assay and uses thereof |
EP2908847B1 (en) | 2012-10-18 | 2022-03-30 | Bioverativ Therapeutics Inc. | Methods of using a fixed dose of a clotting factor |
EP2914293A4 (en) | 2012-10-30 | 2016-04-20 | Biogen Ma Inc | Methods of using fviii polypeptide |
DK3889173T3 (en) | 2013-02-15 | 2023-10-09 | Bioverativ Therapeutics Inc | OPTIMIZED FACTOR VIII GENE |
JP6330026B2 (en) | 2013-03-15 | 2018-05-23 | バイオベラティブ セラピューティクス インコーポレイテッド | Factor VIII polypeptide preparation |
MX2015016567A (en) | 2013-06-28 | 2016-03-31 | Biogen Ma Inc | Thrombin cleavable linker with xten and its uses thereof. |
EP3043813B1 (en) | 2013-08-08 | 2021-01-13 | Bioverativ Therapeutics Inc. | Purification of chimeric fviii molecules |
EP3033097B1 (en) | 2013-08-14 | 2021-03-10 | Bioverativ Therapeutics Inc. | Factor viii-xten fusions and uses thereof |
WO2015070014A1 (en) | 2013-11-08 | 2015-05-14 | Biogen Idec Ma Inc. | Procoagulant fusion compound |
US10325687B2 (en) | 2013-12-06 | 2019-06-18 | Bioverativ Therapeutics Inc. | Population pharmacokinetics tools and uses thereof |
DK4176894T3 (en) | 2014-01-10 | 2024-05-27 | Bioverativ Therapeutics Inc | CHIMERIC FACTOR VIII PROTEINS AND USES THEREOF |
KR20230136616A (en) | 2014-02-04 | 2023-09-26 | 바이오젠 엠에이 인코포레이티드 | Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications |
MA40864A (en) | 2014-10-31 | 2017-09-05 | Biogen Ma Inc | HYPOTAURINE, GABA, BETA-ALANINE AND CHOLINE FOR THE REGULATION OF THE ACCUMULATION OF RESIDUAL BY-PRODUCTS IN MAMMAL CELL CULTURE PROCESSES |
AU2016301303B2 (en) | 2015-08-03 | 2021-10-07 | Bioverativ Therapeutics Inc. | Factor IX fusion proteins and methods of making and using same |
PT3411478T (en) | 2016-02-01 | 2022-09-13 | Bioverativ Therapeutics Inc | Optimized factor viii genes |
EP3548066A1 (en) | 2016-12-02 | 2019-10-09 | Bioverativ Therapeutics Inc. | Methods of treating hemophilic arthropathy using chimeric clotting factors |
BR112019011198A2 (en) | 2016-12-02 | 2019-12-17 | Bioverativ Therapeutics Inc | methods of inducing immune tolerance to coagulation factors |
SG11202000764RA (en) | 2017-08-09 | 2020-02-27 | Bioverativ Therapeutics Inc | Nucleic acid molecules and uses thereof |
MX2020003351A (en) | 2017-09-27 | 2020-10-12 | Sigilon Therapeutics Inc | Methods, compositions, and implantable elements comprising active cells. |
BR112020015228A2 (en) | 2018-02-01 | 2020-12-29 | Bioverativ Therapeutics Inc. | USE OF LENTIVIRAL VECTORS THAT EXPRESS FACTOR VIII |
US20210145889A1 (en) | 2018-04-04 | 2021-05-20 | Sigilon Therapeutics, Inc. | Methods, compositions, and implantable elements comprising stem cells |
TW202014181A (en) | 2018-04-04 | 2020-04-16 | 美商希吉隆醫療公司 | Implantable particles and related methods |
AU2019270184A1 (en) | 2018-05-18 | 2020-11-26 | Bioverativ Therapeutics Inc. | Methods of treating hemophilia A |
MX2021001599A (en) | 2018-08-09 | 2021-07-02 | Bioverativ Therapeutics Inc | Nucleic acid molecules and uses thereof for non-viral gene therapy. |
UY38389A (en) | 2018-09-27 | 2020-04-30 | Sigilon Therapeutics Inc | IMPLANTABLE DEVICES FOR CELLULAR THERAPY AND RELATED METHODS |
EP3986444A1 (en) | 2019-06-19 | 2022-04-27 | Bioverativ Therapeutics Inc. | Recombinant factor viii-fc for treating hemophilia and low bone mineral density |
AU2022332276A1 (en) | 2021-08-23 | 2024-04-04 | Bioverativ Therapeutics Inc. | Optimized factor viii genes |
WO2023056331A1 (en) | 2021-09-30 | 2023-04-06 | Bioverativ Therapeutics Inc. | Nucleic acids encoding factor viii polypeptides with reduced immunogenicity |
WO2024081310A1 (en) | 2022-10-11 | 2024-04-18 | Sigilon Therapeutics, Inc. | Engineered cells and implantable elements for treatment of disease |
WO2024081309A1 (en) | 2022-10-11 | 2024-04-18 | Sigilon Therapeutics, Inc. | Engineered cells and implantable elements for treatment of disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR910006424B1 (en) * | 1985-08-21 | 1991-08-24 | 인코텍스 비.브이 | Method of manufacturing knitted briefs |
US5451521A (en) * | 1986-05-29 | 1995-09-19 | Genetics Institute, Inc. | Procoagulant proteins |
IL83192A (en) * | 1986-07-18 | 1992-11-15 | Gist Brocades Nv | Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies |
AU606925B2 (en) * | 1987-01-30 | 1991-02-21 | Biogen, Inc. | A method for producing factor viii in high yield |
EP0690126B1 (en) * | 1987-06-12 | 2001-11-28 | Baxter Aktiengesellschaft | Novel proteins with factor VIII activitiy: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
-
1987
- 1987-06-19 DE DE19873720246 patent/DE3720246A1/en not_active Withdrawn
-
1988
- 1988-06-11 EP EP88109349A patent/EP0295597A3/en not_active Withdrawn
- 1988-06-16 FI FI882890A patent/FI882890A/en not_active Application Discontinuation
- 1988-06-17 DK DK332888A patent/DK332888A/en not_active Application Discontinuation
- 1988-06-17 JP JP63148402A patent/JPS6425799A/en active Pending
- 1988-06-17 KR KR1019880007295A patent/KR890000666A/en not_active Application Discontinuation
- 1988-06-17 PT PT87752A patent/PT87752B/en not_active IP Right Cessation
- 1988-06-17 AU AU18103/88A patent/AU609829B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JPS6425799A (en) | 1989-01-27 |
PT87752B (en) | 1992-10-30 |
AU1810388A (en) | 1988-12-22 |
EP0295597A2 (en) | 1988-12-21 |
FI882890A0 (en) | 1988-06-16 |
DE3720246A1 (en) | 1988-12-29 |
EP0295597A3 (en) | 1990-05-02 |
PT87752A (en) | 1988-07-01 |
FI882890A (en) | 1988-12-20 |
DK332888D0 (en) | 1988-06-17 |
AU609829B2 (en) | 1991-05-09 |
KR890000666A (en) | 1989-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK332888D0 (en) | FACTOR VIII: C-DERIVATIVE, ITS MANUFACTURING AND USE | |
DK656189A (en) | STABILIZED SUCRALOS COMPLEX, ITS MANUFACTURING AND USE | |
DK223388A (en) | SUBSTRATE, ITS MANUFACTURING AND USE | |
DK537089D0 (en) | SYNERGISTIC SWEATER, ITS MANUFACTURING AND USE | |
NO851563L (en) | FUNCTIONAL, HUMAN FACTOR VIII AND PROCEDURES FOR PRODUCING THEREOF. | |
DK609689A (en) | FOLIAMINATE AND ITS USE | |
DK555586D0 (en) | HARDENING PRODUCT, ITS MANUFACTURING AND USE | |
NO882385L (en) | POLYPEPTIME AND PRODUCTION THEREOF. | |
DK285388A (en) | PEPTIME AND ITS USE | |
NO891334L (en) | SUPERLY MATERIAL AND PROCEDURE FOR ITS MANUFACTURING. | |
DK87487A (en) | FUNGICID AGENT, ITS MANUFACTURING AND USE | |
DK668988D0 (en) | MONOAZOPIGMENTS, THEIR MANUFACTURING AND USE | |
DK388489D0 (en) | SYNERGISTIC SWEATER, ITS MANUFACTURING AND USE | |
DK525687D0 (en) | ENZYMOUS PREPARATION, ITS MANUFACTURING AND USE | |
DK408688D0 (en) | AUTODESINFINING PRINT MATERIAL, ITS MANUFACTURING AND USE | |
NO881902D0 (en) | SOPPAROMA AND MANUFACTURING THEREOF. | |
NO884120D0 (en) | SUPERVISIVE MATERIAL AND PROCEDURE FOR ITS MANUFACTURING. | |
DK125087A (en) | EFOMYCIN G., ITS MANUFACTURING AND USE | |
DK285288D0 (en) | PEPTIME AND ITS USE | |
DK144084A (en) | MAKROLID, ITS MANUFACTURING AND USE | |
DK587588D0 (en) | POLYPEPTID, ITS USE AND MANUFACTURING | |
DK587688D0 (en) | POLYPEPTID, ITS USE AND MANUFACTURING | |
DK690587D0 (en) | TETRAPEPTIME, ITS MANUFACTURING AND USE | |
DK545287A (en) | HYBRID PLASMID ITS MANUFACTURING AND USE | |
DK294987D0 (en) | PLASMID, CALLED PADE161, ITS MANUFACTURING AND USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |